ClinicalTrials.Veeva

Menu

Follow-Up Study for Men Diagnosed With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program

N

National Center for Research Resources (NCRR)

Status

Completed

Conditions

Prostate Cancer

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT00035217
NCRR-M01RR00036-0838

Details and patient eligibility

About

There is controversy concerning the preferred treatment for men with localized prostate cancer with regard to the relative effectiveness of different treatments in controlling the cancer and how different treatments affect the patient's quality of life. The purpose of this research is to describe the disease course of prostate cancer and to determine the effectiveness, potential complications, and quality of life after different treatments in men with prostate cancer detected via screening with prostate-specific antigen (PSA) and/or digital rectal examination

Sex

Male

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Men with prostate cancer diagnosed through the PSA screening study

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems